Capstone Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$7.98M Buy
102,457
+1,485
+1% +$116K 0.22% 119
2017
Q1
$7.27M Buy
100,972
+8,909
+10% +$641K 0.2% 124
2016
Q4
$5.71M Buy
92,063
+4,375
+5% +$271K 0.16% 143
2016
Q3
$5.68M Buy
87,688
+1,715
+2% +$111K 0.16% 142
2016
Q2
$5.44M Buy
85,973
+2,540
+3% +$161K 0.16% 140
2016
Q1
$4.82M Buy
83,433
+70,582
+549% +$4.08M 0.14% 179
2015
Q4
$690K Buy
12,851
+10
+0.1% +$537 0.02% 727
2015
Q3
$654K Buy
12,841
+1,530
+14% +$77.9K 0.02% 747
2015
Q2
$638K Sell
11,311
-100
-0.9% -$5.64K 0.02% 792
2015
Q1
$819K Buy
11,411
+1,010
+10% +$72.5K 0.02% 767
2014
Q4
$583K Sell
10,401
-190
-2% -$10.7K 0.02% 943
2014
Q3
$522K Buy
10,591
+170
+2% +$8.38K 0.02% 989
2014
Q2
$528K Sell
10,421
-2,250
-18% -$114K 0.02% 1028
2014
Q1
$566K Sell
12,671
-1,330
-9% -$59.4K 0.02% 970
2013
Q4
$659K Sell
14,001
-11,759
-46% -$553K 0.02% 901
2013
Q3
$1.36M Buy
25,760
+650
+3% +$34.3K 0.03% 611
2013
Q2
$1.13M Buy
+25,110
New +$1.13M 0.03% 641